What is the recommended treatment and follow‑up for neurosyphilis, including management of a severe penicillin allergy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Neurosyphilis Treatment and Management

Primary Treatment Recommendation

Treat neurosyphilis with intravenous aqueous crystalline penicillin G 18–24 million units per day (administered as 3–4 million units IV every 4 hours or continuous infusion) for 10–14 days. 1, 2


Standard Treatment Regimens

First-Line Therapy

  • Aqueous crystalline penicillin G: 18–24 million units per day IV, given either as 3–4 million units every 4 hours or as continuous infusion, for 10–14 days 1, 2
  • This is the only regimen with proven efficacy for neurosyphilis and must be administered slowly due to sodium content (1.68 mEq per million units) 3

Alternative Regimen (When IV Access Is Problematic)

  • Procaine penicillin 2.4 million units IM once daily PLUS probenecid 500 mg orally four times daily, both for 10–14 days 1, 2
  • Probenecid blocks renal tubular secretion of penicillin, maintaining adequate CSF levels 3
  • Avoid this regimen in patients with sulfa allergy, as probenecid may trigger cross-reactivity 2

Post-Treatment Consolidation

  • Consider adding benzathine penicillin G 2.4 million units IM weekly for up to 3 weeks after completing the neurosyphilis regimen to match the total duration used for late latent syphilis 1, 2

Management of Severe Penicillin Allergy

When Penicillin Cannot Be Used

For patients with documented severe penicillin allergy, penicillin desensitization is the preferred approach rather than using alternative antibiotics. 2

  • Ceftriaxone 2 g daily (IV or IM) for 10–14 days is the only alternative with limited supporting data 1, 2
  • Critical caveat: Cross-reactivity between ceftriaxone and penicillin exists; approximately 1–3% of penicillin-allergic patients will react to cephalosporins 3
  • Skin testing should be performed (if available) to confirm true penicillin allergy before using ceftriaxone 1
  • If concern exists regarding ceftriaxone safety, desensitization in consultation with an allergist/immunologist is mandatory 1, 2

Older Alternatives (Not Recommended)

  • Chloramphenicol and tetracycline have historical case reports but lack adequate evidence and are not included in current guidelines 4
  • Do not use these agents given the availability of desensitization protocols 2

Mandatory Diagnostic Workup

Cerebrospinal Fluid Examination

  • CSF analysis is required for all patients with suspected neurosyphilis, regardless of HIV status 2
  • Perform lumbar puncture before initiating therapy when clinically feasible, but do not delay treatment if CSF cannot be obtained immediately 2
  • Key CSF parameters to assess:
    • Cell count (pleocytosis is the most sensitive marker) 1
    • Protein concentration 1
    • CSF-VDRL (highly specific but only 30–70% sensitive) 1

HIV Testing

  • All patients diagnosed with syphilis must be tested for HIV 1, 2
  • HIV-positive patients may have atypical serologic responses and higher rates of neurologic complications 1

Follow-Up Protocol

CSF Monitoring

  • If initial CSF showed pleocytosis: Repeat lumbar puncture every 6 months until the cell count normalizes 1, 2
  • CSF leukocyte count is the most sensitive measure of treatment effectiveness 1, 2
  • Consider retreatment if:
    • Cell count has not decreased after 6 months 1, 2
    • CSF cell count or protein is not normal after 2 years 1, 2

Serologic Monitoring

  • Obtain quantitative nontreponemal test titers (RPR or VDRL) at 3,6,9,12, and 24 months post-therapy 2
  • Normalization of serum RPR predicts normalization of CSF parameters in immunocompetent and HIV-infected patients on antiretroviral therapy 1

Critical Pitfalls to Avoid

Common Treatment Errors

  • Never use intramuscular benzathine penicillin alone for neurosyphilis—it does not achieve adequate CSF concentrations 2
  • Do not use procaine penicillin without probenecid—monotherapy fails to reach therapeutic CSF levels 2
  • Avoid bacteriostatic antibiotics (chloramphenicol, erythromycins, sulfonamides, tetracyclines) as they may antagonize penicillin's bactericidal effect 3

Monitoring Considerations

  • Monitor electrolyte balance closely during high-dose IV penicillin therapy (>10 million units daily) due to sodium load 3
  • Watch for Clostridium difficile-associated diarrhea, which can occur with any antibacterial agent including penicillin 3
  • Assess renal, hepatic, and hematopoietic function periodically during prolonged therapy 3

Diagnostic Cautions

  • False-positive urine glucose may occur with Benedict's solution, Fehling's solution, or Clinitest tablets (but not enzyme-based tests like Clinistix) 3
  • Penicillin G can cause pseudoproteinuria with certain assay methods 3

Special Populations

HIV-Coinfected Patients

  • Use the same treatment regimens as HIV-negative patients 1
  • No evidence supports additional doses of benzathine penicillin G or other modifications 1
  • Careful follow-up is essential due to potentially higher rates of serologic treatment failure 1

Ocular Syphilis

  • Treat identically to neurosyphilis with IV aqueous crystalline penicillin G 2
  • Co-manage with ophthalmology for appropriate ocular assessment and monitoring 2
  • CSF examination is mandatory even if ocular disease is the only manifestation 2

Pregnancy and Nursing

  • Penicillin G has shown no evidence of fetal harm in animal studies and extensive human experience 3
  • Use during pregnancy when clearly needed 3
  • Penicillin is excreted in breast milk; exercise caution in nursing mothers 3

References

Guideline

sexually transmitted diseases treatment guidelines, 2010.

MMWR Recommendations and Reports, 2010

Guideline

Ocular Syphilis – CDC‑Based Clinical Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Treatment of neurosyphilis with chloramphenicol. A case report.

The British journal of venereal diseases, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.